• Published On : Jan-2017 |
  • Pages : 249 Pages |
  • Format :

Table of Contents

1. Executive Summary

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Global Sterile Injectable Drugs Market Analysis Scenario
   3.1. Market Size (US$ Bn) and Forecast
        3.1.1. Market Size and Y-o-Y Growth
        3.1.2. Absolute $ Opportunity
   3.2. Market Overview
        3.2.1. Value Chain

4. Market Dynamics
   4.1. Macro-economic Factors
   4.2. Drivers
        4.2.1. Supply Side
        4.2.2. Demand Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Forecast Factors – Relevance and Impact
   4.6. Patent Expiries

5. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Molecules 
   5.1. Introduction
   5.2. Basis Point Share (BPS) Analysis By Molecules Type
   5.3. Y-o-Y Growth Projections By Molecules Type
   5.4. Market Value Forecast By Molecules, 2016–2024
        5.4.1. Large Molecules
        5.4.2. Small Molecules
   5.5. Market Attractiveness By Molecules 

6. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Drugs 
   6.1. Introduction
   6.2. Basis Point Share (BPS) Analysis By Drugs 
   6.3. Y-o-Y Growth Projections By Drugs 
   6.4. Market Value Forecast By Drugs , 2016–2024
        6.4.1. Monoclonal Antibodies (Mabs)
        6.4.2. Cytokines
        6.4.3. Insulin
        6.4.4. Peptide Hormones
        6.4.5. Vaccines
        6.4.6. Immunoglobulins
        6.4.7. Blood Factors
        6.4.8. Peptide Antibiotics
        6.4.9. Others
   6.5. Market Attractiveness By Drugs 

7. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Application 
   7.1. Introduction
   7.2. Basis Point Share (BPS) Analysis By Application 
   7.3. Y-o-Y Growth Projections By Application 
   7.4. Market Value Forecast By Application, 2016–2024
        7.4.1. Cancer
        7.4.2. Diabetes
        7.4.3. Cardiovascular Diseases
        7.4.4. Musculoskeletal
        7.4.5. CNS
        7.4.6. Infections
        7.4.7. Others
   7.5. Market Attractiveness By Application 

8. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Route of Administration 
   8.1. Introduction
   8.2. Basis Point Share (BPS) Analysis By Route of Administration 
   8.3. Y-o-Y Growth Projections By Route of Administration 
   8.4. Market Value Forecast By Route of Administration, 2016–2024
        8.4.1. Intravenous (IV)
        8.4.2. Intramuscular (IM)
        8.4.3. Subcutaneous (SC)
        8.4.4. Others
   8.5. Market Attractiveness By Route of Administration 

9. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Distribution Channel 
   9.1. Introduction
   9.2. Basis Point Share (BPS) Analysis By Distribution Channel 
   9.3. Y-o-Y Growth Projections By Distribution Channel 
   9.4. Market Value Forecast By Distribution Channel , 2019–2024
        9.4.1. Hospitals Pharmacies
        9.4.2. Retail Pharmacies
        9.4.3. Online Pharmacies
   9.5. Market Attractiveness By Distribution Channel 

10. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Region
   10.1. Basis Point Share (BPS) Analysis By Region
   10.2. Y-o-Y Growth Projections By Region
   10.3.Market Value Forecast By Region
        10.3.1. North America 
        10.3.2. Latin America 
        10.3.3. Europe 
        10.3.4. APEJ 
        10.3.5. MEA 
   10.4.Market Attractiveness By Region

11. North America Sterile Injectable Drugs Market Analysis and Forecast
   11.1.Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Country
        11.1.2. Y-o-Y Growth Projections By Country
   11.2.Market Value Forecast By Molecules, 2016–2024
        11.2.1. Large Molecules
        11.2.2. Small Molecules
   11.3.Market Value Forecast By Distribution Channel , 2016–2024
        11.3.1. Hospitals Pharmacies
        11.3.2. Retail Pharmacies
        11.3.3. Online Pharmacies
   11.4.Market Value Forecast By Drugs , 2016–2024
        11.4.1. Monoclonal Antibodies (Mabs)
        11.4.2. Cytokines
        11.4.3. Insulin
        11.4.4. Peptide Hormones
        11.4.5. Vaccines
        11.4.6. Immunoglobulins
        11.4.7. Blood Factors
        11.4.8. Peptide Antibiotics
        11.4.9. Others
   11.5.Market Value Forecast By Application, 2016–2024
        11.5.1. Cancer
        11.5.2. Diabetes
        11.5.3. Cardiovascular Diseases
        11.5.4. Musculoskeletal
        11.5.5. CNS
        11.5.6. Infections
        11.5.7. Others
   11.6.Market Value Forecast By Route of Administration, 2016–2024
        11.6.1. Intravenous (IV)
        11.6.2. Intramuscular (IM)
        11.6.3. Subcutaneous (SC)
        11.6.4. Others
   11.7.Market Value Forecast By Country, 2016–2024
        11.7.1. US
        11.7.2. Canada
   11.8.Market Attractiveness Analysis 
        11.8.1. By Molecules 
        11.8.2. By Distribution Channel 
        11.8.3. By Drugs 
        11.8.4. By Application 
        11.8.5. By Route of Administration 
        11.8.6. By Country
   11.9. Prominent Trends 

12. Latin America Sterile Injectable Drugs Market Analysis and Forecast
   12.1.Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Country
        12.1.2. Y-o-Y Growth Projections By Country
   12.2.Market Value Forecast By Molecules, 2016–2024
        12.2.1. Large Molecules
        12.2.2. Small Molecules
   12.3.Market Value Forecast By Distribution Channel , 2016–2024
        12.3.1. Hospitals Pharmacies
        12.3.2. Retail Pharmacies
        12.3.3. Online Pharmacies
   12.4.Market Value Forecast By Drugs , 2016–2024
        12.4.1. Monoclonal Antibodies (Mabs)
        12.4.2. Cytokines
        12.4.3. Insulin
        12.4.4. Peptide Hormones
        12.4.5. Vaccines
        12.4.6. Immunoglobulins
        12.4.7. Blood Factors
        12.4.8. Peptide Antibiotics
        12.4.9. Others
   12.5.Market Value Forecast By Application, 2016–2024
        12.5.1. Cancer
        12.5.2. Diabetes
        12.5.3. Cardiovascular Diseases
        12.5.4. Musculoskeletal
        12.5.5. CNS
        12.5.6. Infections
        12.5.7. Others
   12.6.Market Value Forecast By Route of Administration, 2016–2024
        12.6.1. Intravenous (IV)
        12.6.2. Intramuscular (IM)
        12.6.3. Subcutaneous (SC)
        12.6.4. Others
   12.7.Market Value Forecast By Country, 2016–2024
        12.7.1. Brazil
        12.7.2. Mexico
        12.7.3. Rest of Latin America
   12.8.Market Attractiveness Analysis 
        12.8.1. By Molecules 
        12.8.2. By Distribution Channel 
        12.8.3. By Drugs 
        12.8.4. By Application 
        12.8.5. By Route of Administration 
        12.8.6. By Country
   12.9. Prominent Trends 

13. Europe Sterile Injectable Drugs Market Analysis and Forecast
   13.1.Introduction
        13.1.1. Basis Point Share (BPS) Analysis By Country
        13.1.2. Y-o-Y Growth Projections By Country
   13.2.Market Value Forecast By Molecules, 2016–2024
        13.2.1. Large Molecules
        13.2.2. Small Molecules
   13.3.Market Value Forecast By Distribution Channel , 2016–2024
        13.3.1. Hospitals Pharmacies
        13.3.2. Retail Pharmacies
        13.3.3. Online Pharmacies
   13.4.Market Value Forecast By Drugs , 2016–2024
        13.4.1. Monoclonal Antibodies (Mabs)
        13.4.2. Cytokines
        13.4.3. Insulin
        13.4.4. Peptide Hormones
        13.4.5. Vaccines
        13.4.6. Immunoglobulins
        13.4.7. Blood Factors
        13.4.8. Peptide Antibiotics
        13.4.9. Others
   13.5.Market Value Forecast By Application, 2016–2024
        13.5.1. Cancer
        13.5.2. Diabetes
        13.5.3. Cardiovascular Diseases
        13.5.4. Musculoskeletal
        13.5.5. CNS
        13.5.6. Infections
        13.5.7. Others
   13.6.Market Value Forecast By Route of Administration, 2016–2024
        13.6.1. Intravenous (IV)
        13.6.2. Intramuscular (IM)
        13.6.3. Subcutaneous (SC)
        13.6.4. Others
   13.7.Market Value Forecast By Country, 2016–2024
        13.7.1. UK
        13.7.2. France
        13.7.3. Germany
        13.7.4. Italy
        13.7.5. Spain
        13.7.6. Russia
        13.7.7. Rest of Europe
   13.8.Market Attractiveness Analysis 
        13.8.1. By Molecules 
        13.8.2. By Distribution Channel 
        13.8.3. By Drugs 
        13.8.4. By Application 
        13.8.5. By Route of Administration 
        13.8.6. By Country
   13.9. Prominent Trends 

14. APEJ Sterile Injectable Drugs Market Analysis and Forecast
   14.1.Introduction
        14.1.1. Basis Point Share (BPS) Analysis By Country
        14.1.2. Y-o-Y Growth Projections By Country
   14.2.Market Value Forecast By Molecules, 2016–2024
        14.2.1. Large Molecules
        14.2.2. Small Molecules
   14.3.Market Value Forecast By Distribution Channel , 2016–2024
        14.3.1. Hospitals Pharmacies
        14.3.2. Retail Pharmacies
        14.3.3. Online Pharmacies
   14.4.Market Value Forecast By Drugs , 2016–2024
        14.4.1. Monoclonal Antibodies (Mabs)
        14.4.2. Cytokines
        14.4.3. Insulin
        14.4.4. Peptide Hormones
        14.4.5. Vaccines
        14.4.6. Immunoglobulins
        14.4.7. Blood Factors
        14.4.8. Peptide Antibiotics
        14.4.9. Others
   14.5.Market Value Forecast By Application, 2016–2024
        14.5.1. Cancer
        14.5.2. Diabetes
        14.5.3. Cardiovascular Diseases
        14.5.4. Musculoskeletal
        14.5.5. CNS
        14.5.6. Infections
        14.5.7. Others
   14.6.Market Value Forecast By Route of Administration, 2016–2024
        14.6.1. Intravenous (IV)
        14.6.2. Intramuscular (IM)
        14.6.3. Subcutaneous (SC)
        14.6.4. Others
   14.7.Market Value Forecast By Country, 2016–2024
        14.7.1. Japan
        14.7.2. China
        14.7.3. India
        14.7.4. Australia & New Zealand
        14.7.5. ASEAN
        14.7.6. Rest of APAC
   14.8.Market Attractiveness Analysis 
        14.8.1. By Molecules 
        14.8.2. By Distribution Channel 
        14.8.3. By Drugs 
        14.8.4. By Application 
        14.8.5. By Route of Administration 
        14.8.6. By Country
   14.9. Prominent Trends 

15. MEA Sterile Injectable Drugs Market Analysis and Forecast
   15.1.Introduction
        15.1.1. Basis Point Share (BPS) Analysis By Country
        15.1.2. Y-o-Y Growth Projections By Country
   15.2.Market Value Forecast By Molecules, 2016–2024
        15.2.1. Large Molecules
        15.2.2. Small Molecules
   15.3.Market Value Forecast By Distribution Channel , 2016–2024
        15.3.1. Hospitals Pharmacies
        15.3.2. Retail Pharmacies
        15.3.3. Online Pharmacies
   15.4.Market Value Forecast By Drugs , 2016–2024
        15.4.1. Monoclonal Antibodies (Mabs)
        15.4.2. Cytokines
        15.4.3. Insulin
        15.4.4. Peptide Hormones
        15.4.5. Vaccines
        15.4.6. Immunoglobulins
        15.4.7. Blood Factors
        15.4.8. Peptide Antibiotics
        15.4.9. Others
   15.5.Market Value Forecast By Application, 2016–2024
        15.5.1. Cancer
        15.5.2. Diabetes
        15.5.3. Cardiovascular Diseases
        15.5.4. Musculoskeletal
        15.5.5. CNS
        15.5.6. Infections
        15.5.7. Others
   15.6.Market Value Forecast By Route of Administration, 2016–2024
        15.6.1. Intravenous (IV)
        15.6.2. Intramuscular (IM)
        15.6.3. Subcutaneous (SC)
        15.6.4. Others
   15.7.Market Value Forecast By Country, 2016–2024
        15.7.1. GCC Countries
        15.7.2. South Africa
        15.7.3. North Africa
        15.7.4. Rest of MEA
   15.8.Market Attractiveness Analysis 
        15.8.1. By Molecules 
        15.8.2. By Distribution Channel 
        15.8.3. By Drugs 
        15.8.4. By Application 
        15.8.5. By Route of Administration 
        15.8.6. By Country
   15.9. Prominent Trends 

16. Competition Landscape
   16.1. Competition Dashboard
   16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
        16.2.1. Baxter International Inc.
        16.2.2. Sanofi
        16.2.3. Pfizer Inc.
        16.2.4. GlaxoSmithKline plc.
        16.2.5. AstraZeneca
        16.2.6. GILEAD SCIENCES, INC.
        16.2.7. Merck & Co., Inc.
        16.2.8. Novartis AG
        16.2.9. Johnson & Johnson Services, Inc.
        16.2.10. Nova Nordisk A/S

17. Assumptions and Acronyms Used

18. Research Methodology


List of Tables

Table 01: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 02: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 03: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 04: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 05: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 06: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Region, 2015–2024
Table 07: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 08: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 09: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 10: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 11: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 12: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
Table 13: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 14: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 15: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 16: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 17: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 18: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
Table 19: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 20: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 21: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 22: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 23: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 24: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 25: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 26: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 27: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 28: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 29: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 30: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 31: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 32: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 33: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 34: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 35: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 36: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024


List of Figures

Figure 01: Global Sterile Injectable Drugs Market – Scenario Forecast, 2016–2024 (US$ Bn)
Figure 02 : Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 03 : Global Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 04 : Global Sterile Injectable Drugs Market Share Analysis (%) By Molecule Type, 2016 & 2024
Figure 05 : Global Sterile Injectable Drugs Y-o-Y growth (%) By Molecule Type, 2016–2024
Figure 06: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Small Molecules Segment, 
2015–2024
Figure 07: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Small Molecules Segment, 2016–2024
Figure 08: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Large Molecules Segment, 
2015–2024
Figure 09: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Large Molecules Segment, 2016–2024
Figure 10: Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2016–2024
Figure 11: Global Sterile Injectable Drugs Market Share Analysis (%) By Drug Type, 2016 & 2024
Figure 12: Global Sterile Injectable Drugs Y-o-Y growth (%) By Drug Type, 2016–2024
Figure 13: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Monoclonal Antibodies (mAbs) 
Segment, 2015–2024
Figure 14: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Monoclonal Antibodies (mAbs) Segment, 
2016–2024
Figure 15: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cytokines Segment, 2015–2024
Figure 16: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cytokines Segment, 2016–2024
Figure 17: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Insulin Segment, 2015–2024
Figure 18: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Insulin Segment, 2016–2024
Figure 19: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Hormones Segment, 
2015–2024
Figure 20: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Hormones Segment, 2016–2024
Figure 21: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) Vaccines Segment, 2015–2024
Figure 22: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Vaccines Segment, 2016–2024
Figure 23: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Immunoglobulins Segment, 
2015–2024
Figure 24: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Immunoglobulins Segment, 2016–2024
Figure 25: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Blood Factors Segment, 
2015–2024
Figure 26: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Blood Factors Segment, 2016–2024
Figure 27: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Antibiotics Segment, 
2015–2024
Figure 28: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Antibiotics Segment, 2016–2024
Figure 29: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 30: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 31: Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 32: Global Sterile Injectable Drugs Market Share Analysis (%) By Application, 2016 & 2024
Figure 33: Global Sterile Injectable Drugs Y-o-Y growth (%) By Application, 2016–2024
Figure 34: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cancer Segment, 2015–2024
Figure 35: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cancer Segment, 2016–2024
Figure 36: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Diabetes Segment, 2015–2024
Figure 37: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Diabetes Segment, 2016–2024
Figure 38: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cardiovascular Diseases Segment,
 2015–2024
Figure 39: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cardiovascular Diseases Segment, 2016–2024
Figure 40: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Musculoskeletal Segment,
 2015–2024
Figure 41: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Musculoskeletal Segment, 2016–2024
Figure 42: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By CNS Segment, 2015–2024
Figure 43: Global Sterile Injectable Drugs Market Absolute $ Opportunity By CNS Segment, 2016–2024
Figure 44: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Infections Segment, 2015–2024
Figure 45: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Infections Segment, 2016–2024
Figure 46: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 47: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 48: Global Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 49: Global Sterile Injectable Drugs Market Share Analysis (%) By Routes of Administration, 2016 & 2024
Figure 50: Global Sterile Injectable Drugs Y-o-Y growth (%) By Routes of Administration, 2016–2024
Figure 51: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intravenous (IV) Segment, 
2015–2024
Figure 52: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intravenous (IV) Segment, 2016–2024
Figure 53: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intramuscular (IM) Segment, 2015–2024
Figure 54: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intramuscular (IM) Segment, 2016–2024
Figure 55: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Subcutaneous (SC) Segment, 2015–2024
Figure 56: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Subcutaneous (SC) Segment, 2016–2024
Figure 57: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 58: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 59: Global Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 60: Global Sterile Injectable Drugs Market Share Analysis (%) By Distribution Channel, 2016 & 2024
Figure 61: Global Sterile Injectable Drugs Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 62: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Hospital Pharmacies Segment, 2015–2024
Figure 63: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Hospital Pharmacies Segment, 2016–2024
Figure 64: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Retail Pharmacies Segment, 2015–2024
Figure 65: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016–2024
Figure 66: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Online Pharmacies Segment, 2015–2024
Figure 67: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Online Pharmacies Segment, 2016–2024
Figure 68: Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 69: Global Sterile Injectable Drugs Market Share Analysis (%) By Region, 2016 & 2024
Figure 70: Global Sterile Injectable Drugs Y-o-Y growth (%) By Region, 2016–2024
Figure 71: North America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 72: North America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 73: Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 74: Latin America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 75: Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 76: Europe Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 77: APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 78: APAC Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 79: MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 80: MEA Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 81: Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2016–2024
Figure 82: North America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 83: North America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 84: U.S. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 85: U.S. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 86: Canada Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 87: Canada Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 88: North America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 89: North America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 90: North America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 91: North America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 92: North America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 93: North America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 94: Latin America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 95: Latin America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 96: Brazil Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 97: Brazil Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 98: Mexico Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 99: Mexico Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 100: Rest of Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 101: Rest of Latin America Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 102: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 103: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 104: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 105: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 106: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 107: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure  108: Europe Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 109: Europe Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 110: Germany Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 111: Germany Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 112: France Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 113: France Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 114: Russia Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 115: Russia Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 116: Italy Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 117: Italy Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 118: Spain Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 119: Spain Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 120: U.K. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 121: U.K. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 122: Rest of Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 123: Rest of Europe Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 124: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 125: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 126: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 127: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 128: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 129: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 130: APAC Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 131: APAC Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 132: China Sterile Injectable Drugs Market Value
Figure 133: China Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024
Figure 134: India Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 135: India Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 136: Japan Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 137: Japan Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 138: Australia & New Zealand Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 139: Australia & New Zealand Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 140: ASEAN Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 141: ASEAN Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 142: Rest of APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 143: Rest of APAC Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 144: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 145: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 146: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 147: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 148: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 149: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 150: MEA Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 151: MEA Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 152: GCC Countries Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 153: GCC Countries Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 154: South Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 155: South Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 156: North Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 157: North Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 158: Rest of MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 159: Rest of MEA Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024
Figure 160:  MEA Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 161: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 162: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 163: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 164: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 165: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024